Arimidex is now approved to treat EARLY breast cancer
October 2002
Arimidex is now approved to treat EARLY breast cancer.
Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.
Both tamoxifen and Arimidex reduce the effect of estrogen on tumor cells...but they work in different ways. Tamoxifen blocks estrogen receptors...Arimidex suppresses estrogen synthesis.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote